🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Gaurav Maini

Stock Analyst at LifeSci Capital

(0.09)
# 4,846
Out of 5,152 analysts
53
Total ratings
11.1%
Success rate
-32.9%
Average return

Stocks Rated by Gaurav Maini

Hemab Therapeutics Holdings
Nov 9, 2026
Initiated Coverage: Buy
Price Target: $65
Current: $39.06
Upside: +66.41%
Liquidia
Oct 14, 2026
Upgraded: Buy
Price Target: $59
Current: $56.73
Upside: +4.00%
Contineum Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $23
Current: $9.55
Upside: +140.84%
Tectonic Therapeutic
Sep 29, 2026
Reiterated: Buy
Price Target: $88
Current: $20.08
Upside: +338.25%
Sionna Therapeutics
Sep 19, 2026
Reiterated: Hold
Price Target: $6
Current: $3.07
Upside: +95.44%
Inhibikase Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $5
Current: $1.42
Upside: +252.11%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.58
Upside: +424.02%